/Companies

Fuse Biotherapeutics

Los Angeles, US · Founded 2021 · Delaware corporation

Find your way into Fuse Biotherapeutics

Sign up to see every warm intro you have to Fuse Biotherapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Fuse Biotherapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

YW
Yuanheng Wang LiangNamed on SEC filing
JT
Jeffrey TakimotoNamed on SEC filing
BR
Brian RabinovichNamed on SEC filing
PS
Paul SongNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$8.2M disclosed across 1 round · 2021

▶$8.2MraisedNov 2021 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Yuanheng Wang LiangDirector
  • Jeffrey TakimotoExecutive Officer
  • Brian RabinovichExecutive Officer, Director
  • Paul SongExecutive Officer, Director
Offering amount
$9.6M
Amount sold
$8.2M
First sale
Jun 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Fuse Biotherapeutics raised?
Fuse Biotherapeutics has disclosed $8.2M raised across 1 round.
Where is Fuse Biotherapeutics headquartered?
Fuse Biotherapeutics is headquartered in Los Angeles, US.